<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Nutrition And Food In Health And Disease</title>
<title_fa>1</title_fa>
<short_title>Nutr Food Health Dis</short_title>
<subject>Medical Sciences</subject>
<web_url>http://nfsr.sbmu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2383-0441</journal_id_issn>
<journal_id_issn_online>2383-3009</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/nfsr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2024</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Assessing Effects of Serum 25-Hydroxyvitamin D Levels on Anxiety and Depression in Patients with Colorectal Adenocarcinoma</title>
	<subject_fa>Nutrition</subject_fa>
	<subject>Nutrition</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;tab-stops:409.5pt&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Background and Objectives: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;In colorectal cancer patients experiencing depression and anxiety, vitamin D supplementation may boost mood by rectifying serum 25(OH)D levels. This study assessed the potential for vitamin D to alleviate symptoms of depression and anxiety in colorectal cancer patients with insufficient clinical evidence available.&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;tab-stops:409.5pt&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Materials and Methods: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;In this study,&lt;b&gt; &lt;/b&gt;46 colorectal adenocarcinoma patients were included based on specific inclusion criteria. &lt;span style=&quot;background:white&quot;&gt;Serum 25(OH)D&lt;/span&gt; levels were assessed using enzyme-linked immunosorbent assay and assessed anxiety and depression using Zung&amp;#39;s questionnaire at baseline. Based on the baseline &lt;span style=&quot;background:white&quot;&gt;serum 25(OH)D&lt;/span&gt; levels, patients were categorized into four groups of &lt; 12 ng/ml, 12&amp;ndash;20 ng/ml, 20&amp;ndash;30 ng/ml and &amp;ge; 30 ng/ml. A standard dose of vitamin D supplementation was administered based on the study protocol. After 12 w, &lt;span style=&quot;background:white&quot;&gt;serum 25(OH)D&lt;/span&gt; levels, anxiety and depression were assessed and statistical analyses were carried out.&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;tab-stops:409.5pt&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;In this clinical trial, 80% of patients (median age, 56.8 y) had inadequate baseline &lt;span style=&quot;background:white&quot;&gt;serum 25(OH)D&lt;/span&gt; levels (&lt; 30 ng/ml), with 28.3% having depressive symptoms (Zung SDS score &gt; 50) and 37% showing anxiety symptoms (Zung SAS score &amp;ge; 40). The average &lt;span style=&quot;background:white&quot;&gt;serum 25(OH)D&lt;/span&gt; level increased from 25.4 ng/ml before the intervention to 34.8 ng/ml post-intervention. Significant differences were reported in &lt;span style=&quot;background:white&quot;&gt;serum 25(OH)D&lt;/span&gt; levels before and after the intervention (&lt;i&gt;p &lt;/i&gt;= 0.0001). Additionally, significant decreases were reported in the mean scores for anxiety (&lt;i&gt;p &lt;/i&gt;= 0.021) and depression (&lt;i&gt;p &lt;/i&gt;= 0.015) after the intervention. Changes in &lt;span style=&quot;background:white&quot;&gt;serum 25(OH)D&lt;/span&gt; levels were significant and inversely correlated with changes in depression (&lt;i&gt;p &lt;/i&gt;= 0.0186) and anxiety (&lt;i&gt;p &lt;/i&gt;= 0.0099) scores.&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;tab-stops:409.5pt&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Conclusions: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;Vitamin D supplementation may significantly improve depression and anxiety symptoms in colorectal adenocarcinoma patients.&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>25-Hydroxyvitamin D, Colorectal cancer, Depression, Anxiety, Clinical trial</keyword>
	<start_page>11</start_page>
	<end_page>21</end_page>
	<web_url>http://nfsr.sbmu.ac.ir/browse.php?a_code=A-10-1135-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Reyhaneh</first_name>
	<middle_name></middle_name>
	<last_name>Entezari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>r.entezariheravi7831@iau.ir</email>
	<code>10031947532846006704</code>
	<orcid>0009-0008-7023-3375</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Student Research Committee, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Vahid</first_name>
	<middle_name></middle_name>
	<last_name>Pouresmaeil</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>vahidpouresmail@yahoo.fr</email>
	<code>10031947532846006705</code>
	<orcid>10031947532846006705</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Biochemistry, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Amir</first_name>
	<middle_name></middle_name>
	<last_name>Amirabadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>amirabadi1980@yahoo.com</email>
	<code>10031947532846006706</code>
	<orcid>10031947532846006706</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Internal Medicine, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad university, Mashhad, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Vahid</first_name>
	<middle_name></middle_name>
	<last_name>Saadatian</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>saadatian1872@gmail.com</email>
	<code>10031947532846006707</code>
	<orcid>10031947532846006707</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Psychiatry, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad university, Mashhad, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Payam</first_name>
	<middle_name></middle_name>
	<last_name>Izadpanahi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>dr.izadpanahi@gmail.com</email>
	<code>10031947532846006708</code>
	<orcid>10031947532846006708</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Reza Radiation Oncology Center, Mashhad, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
